AAP Policy
HOME HELP E-MAIL ALERTS SEARCH

PEDIATRICS Vol. 115 No. 4 April 2005, pp. 1107 (doi:10.1542/peds.2005-0207)
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Endorsed Clinical Practice Guideline

Pharmacological Treatment of Migraine Headache in Children and Adolescents

American Academy of Neurology Quality Standards Subcommittee and Practice Committee of the Child Neurology Society

On November 19, 2004, the American Academy of Pediatrics endorsed the following practice parameter:

Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents. Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215–2224. Available at: www.neurology.org/cgi/reprint/63/12/2215.pdf. Accessed February 1, 2005

FOOTNOTES

All statements of endorsement from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

PEDIATRICS (ISSN 1098-4275). ©2005 by the American Academy of Pediatrics




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP E-MAIL ALERTS SEARCH